BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 13, Issue 34
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study
©The Author(s) 2025.
World J Clin Cases. Dec 6, 2025; 13(34): 111732
Published online Dec 6, 2025. doi: 10.12998/wjcc.v13.i34.111732
Table 2 Comparison of nicotinamide phosphoribosyltransferase and nicotinamide nucleotide adenylyltransferase 1 concentrations among different pneumonia severity index scores, n (%)
PSI classification
Low risk
Medium risk
High risk
NAMPT (pg/mL) (IQR) 35.29 (34.68)2,327.22 (26.23)1,321.19 (21.71)1,2
NMNAT1 (pg/mL) (IQR) 42.49 (44.50)2,326.19 (26.52)1,318.24 (18.77)1,2
1Indicates statistical significance when compared with the low-risk group.
2Indicates statistical significance when compared with the medium-risk group.
3Indicates statistical significance when compared with the high-risk group.
PSI: Pneumonia severity index; IQR: Interquartile range; NAMPT: Nicotinamide phosphoribosyltransferase; NMNAT1: Nicotinamide nucleotide adenylyltransferase 1.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.